Duncan Gould

Duncan Gould has a diverse background in the pharmaceutical industry, starting as a clinician in men's health in 2007. Duncan later held roles as a consultant medical advisor at Bristol Myers Squibb from 2009 to 2011. Subsequently, they worked as a consultant International Medical Director at Gilead Sciences starting in 2010. In 2015, they served as a Consultant Clinical Director at Norgine Pharmaceuticals before becoming the UK Clinical Development Director at Almirall in 2018.

Duncan Gould's education history includes attending Chigwell School for their early education. Duncan later obtained a Doctor of Medicine (MD) from London Hospital Medical College in 1982, followed by a degree in Medicine (MRCGP) from the University of Otago in 1987. In 1991-1992, they pursued a Master of Business Administration (MBA) from the University of Warwick - Warwick Business School. Duncan also received a degree as a Member of the Faculty of Pharmaceutical Physicians from the Royal College of Physicians in 2004 and a FFPM in Medicine from the Royal College of Physicians of England in 2019.